interferon
ifn
mediat
innat
immun
respons
provid
potent
defens
pathogen
upon
invas
pathogenassoci
molecular
pattern
pamp
detect
specif
receptor
cell
locat
surfac
cell
case
tolllik
receptor
tlr
intracellularli
case
retino
acidinduc
gene
rigi
pamp
recognit
trigger
seri
signal
cascad
lead
product
secret
type
ifn
type
ifn
other
bind
ifn
receptor
present
surfac
cell
type
activ
janusactiv
kinasesign
transduc
activ
transcript
jakstat
signal
give
rise
nuclear
transloc
ifn
regulatori
factor
complex
bind
ifnstimul
respons
element
isr
promot
ifnstimul
gene
isg
activ
transcript
similar
respons
induc
type
iii
ifn
upon
bind
receptor
contrast
type
ii
ifn
produc
cell
immun
system
bind
wide
express
receptor
lead
nuclear
transloc
homodim
bind
gammaactiv
sequenc
ga
promot
immunoregulatori
gene
ifnstimul
gene
antivir
factor
posit
regul
ifn
pathway
neg
regul
help
ifninduc
cell
return
cellular
homeostasi
soc
among
antivir
gene
factor
function
increas
cell
sensit
pamp
oa
pkr
true
antivir
effector
block
viral
entri
mx
ifitm
trim
viru
replic
translat
stabil
ifit
oa
pkr
viral
releas
viperin
ifninduc
factor
known
date
protein
ifn
also
activ
express
sever
microrna
contribut
antivir
state
control
ifn
respons
studi
perform
address
whether
ifn
could
also
regul
express
long
noncod
rna
lncrna
recent
year
viral
infect
report
abl
induc
express
cellular
lncrna
shown
infect
enteroviru
influenza
hiv
hepat
b
c
virus
sar
coronaviru
carnero
et
al
prepar
lncrna
signatur
found
infect
mixtur
transcript
induc
viru
transcript
respond
cellular
antivir
pathway
activ
infect
fact
activ
tlr
pamp
induc
express
sever
lncrna
signal
lead
activ
regul
express
gene
relat
immun
system
activ
result
increas
increas
express
gene
control
lncrna
whose
downregul
diminish
accumul
lpsinduc
rna
likewis
lpsinduc
inflammatori
respons
control
innat
activ
also
induc
control
gene
involv
immun
respons
turn
induc
leth
pseudogen
respond
reduc
inflamm
inhibit
dna
bind
activ
lncrna
respons
also
critic
function
dendrit
cell
tcell
thu
nest
lncrna
control
locu
tcell
lead
decreas
salmonella
enterica
pathogenesi
studi
illustr
interest
identifi
novel
lncrna
elucid
function
regul
lncrna
thought
least
numer
proteincod
gene
well
character
lncrna
transcript
similar
mrna
poor
code
potenti
cell
typespecif
less
express
less
well
conserv
mrna
interestingli
lncrna
cell
regul
function
ci
cotranscript
tran
control
express
code
gene
locat
genom
region
therefor
genom
locat
lncrna
provid
hint
function
sens
antisens
overlap
one
exon
anoth
transcript
opposit
strand
respect
intron
deriv
intron
anoth
transcript
diverg
bidirect
share
promot
anoth
transcript
opposit
strand
therefor
coregul
intergen
independ
locat
two
gene
sever
mechan
involv
regul
neighbor
antisens
gene
lncrna
includ
transcript
activ
interfer
recruit
chromatin
modifi
remodel
regul
imprint
edit
splice
translat
stabil
address
issu
whether
ifn
could
also
regul
express
lncrna
may
play
key
role
antivir
respons
analyz
transcriptom
cell
treat
rna
sequenc
rnaseq
analysi
identifi
two
lncrna
upregul
respons
ifn
differ
cell
line
interestingli
lncrna
express
posit
genom
diverg
wellcharacter
isg
therefor
call
lncrna
code
counterpart
also
induc
cell
infect
mutant
influenza
vesicular
stomat
virus
vsv
fail
block
ifn
respons
surprisingli
also
induc
cultur
cell
infect
hepat
c
viru
hcv
liver
patient
hcv
infect
final
accord
hugo
regul
renam
bispr
ifnstimul
posit
regul
show
inhibit
express
rnai
lead
decreas
level
mrna
provid
new
layer
regul
ifn
respons
cell
line
deriv
human
hepatocarcinoma
provid
dr
chisari
lab
scripp
research
institut
la
jolla
ca
usa
cell
human
nonsmal
cell
lung
carcinoma
kindli
provid
estanislao
nistal
cima
univers
navarra
spain
human
liver
sampl
without
hcv
infect
obtain
biobank
univers
navarra
approv
ethic
scientif
committe
liver
tissu
section
snap
frozen
store
clinic
data
hcvinfect
subject
shown
tabl
supplementari
materi
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
maintain
atmospher
twentyfour
hour
treatment
ifn
cell
seed
sixwel
plate
unitsml
sicor
biotech
lithuania
use
final
volum
ml
cell
also
treat
ngml
r
system
final
volum
ml
treatment
ruxolitinib
selleckchem
cell
seed
h
treat
ruxolitinib
final
volum
ml
one
hour
treatment
media
discard
replac
media
contain
unitsml
cell
harvest
rna
extract
indic
time
posttreat
sirna
target
design
use
iscor
design
rna
scale
purchas
dharmacon
sirna
target
sequenc
gacuagugugagcaacaaa
cell
transfect
sirna
lipofectamin
reagent
invitrogen
use
accord
manufactur
instruct
cell
seed
h
transfect
well
sixwel
plate
pmole
sirna
use
sirna
mix
optimem
furthermor
lipofectamin
mix
optimem
media
incub
min
lipofectamin
sirna
solut
mix
incub
min
room
temperatur
incub
half
volum
cell
media
discard
lipofectamin
mixtur
ad
well
plate
respect
six
hour
posttransfect
media
cell
discard
substitut
dmem
media
enrich
fb
antibiot
hepat
c
viru
obtain
initi
viral
stock
genotyp
plasmid
previous
describ
wakita
et
al
viru
amplifi
describ
influenza
viru
strain
wt
mutant
lack
vsvgfp
mutant
kindli
provid
estanislao
nistal
cima
univers
navarra
spain
semliki
forest
viru
sfv
gift
cristian
smerdou
cima
univers
navarra
spain
adenoviru
serotyp
amplifi
previous
describ
vsvegfp
titrat
perform
quadrupl
cell
supernat
infect
cell
collect
serial
dilut
perform
cell
seed
h
infect
plate
infect
dilut
twentyfour
hour
infect
gfp
express
visual
microscopi
use
determin
titer
cell
infect
hcv
multipl
infect
moi
vsv
moi
moi
influenza
sfv
case
lytic
virus
use
moi
caus
cytopath
effect
h
vsv
influenza
sfv
h
ad
cell
infect
viru
remov
fresh
medium
ad
cell
cell
harvest
rna
extract
indic
time
postinfect
two
million
cell
incub
cytoplasm
buffer
mm
tri
hcl
mm
edta
min
cell
centrifug
min
g
supernat
use
isol
cytoplasm
rna
pellet
wash
cytoplasm
buffer
centrifug
supernat
discard
pellet
use
isol
nuclear
rna
rna
nuclear
cytoplasm
fraction
isol
maxwel
research
system
promega
human
tissu
homogen
use
ultraturrax
dispers
machin
basic
ikawerk
total
rna
tissu
extract
ml
trizol
sigmaaldrich
recommend
supplier
follow
dnase
fermenta
treatment
perform
elimin
dna
sampl
rtpcr
reaction
rna
extract
cell
maxwel
research
system
promega
follow
manufactur
recommend
rna
concentr
measur
use
nanodrop
spectrophotomet
qualiti
rna
analyz
bioanalyz
agil
technolog
revers
transcript
rt
perform
describ
reaction
perform
touch
thermal
cycler
biorad
sampl
incub
min
immedi
cool
qpcr
perform
realtim
system
biorad
describ
result
analyz
biorad
cfxmanag
softwar
gapdh
level
evalu
case
refer
sampl
similar
gapdh
amplif
analyz
primer
use
list
tabl
supplementari
materi
design
rna
excel
qualiti
determin
bioanalyz
agil
technolog
treat
ribozero
rrna
remov
kit
epicent
deplet
ribosom
rna
librari
prepar
truseq
rna
sampl
prepar
kit
illumina
sequenc
perform
embl
genom
core
facil
genecor
illumina
hiseq
sequenc
pairedend
base
long
strand
specif
rnaseq
data
avail
ncbi
gene
express
omnibu
geo
data
rna
sequenc
data
analysi
perform
use
follow
workflow
qualiti
sampl
verifi
use
fastqc
softwar
preprocess
read
perform
elimin
contamin
adapt
substr
scyth
qualitybas
trim
use
sickl
align
read
human
genom
perform
use
mapper
transcript
assembl
quantif
use
fpkm
gene
transcript
carri
cufflink
annot
gene
locu
obtain
perform
use
cuffmerg
gencod
refer
differenti
express
analysi
perform
use
cuffdiff
gene
select
differenti
express
use
pvalu
threshold
analysi
graphic
represent
perform
use
rbioconductor
read
differenti
express
sequenc
visual
integr
genom
viewer
igv
sequenc
compar
ensembl
encod
databas
search
genom
browser
inform
candid
divid
code
noncod
accord
ucsc
classif
nonassign
transcript
sequenc
annot
databas
function
enrich
analysi
gene
ontolog
go
categori
carri
use
standard
hypergeometr
test
biolog
knowledg
extract
complement
use
ingenu
pathway
analysi
ingenu
system
databas
includ
manual
curat
fulli
traceabl
data
deriv
literatur
sourc
open
read
frame
finder
ncbi
use
evalu
length
probabl
open
read
frame
orf
code
potenti
assay
code
potenti
assess
tool
cpat
search
lncipedia
databas
presenc
candid
pride
archiv
list
transcript
associ
ribosom
phylogenet
codon
substitut
frequenc
phylocsf
also
use
predict
code
potenti
statist
analysi
rnaseq
data
alreadi
describ
remain
analysi
perform
use
graphpath
statist
signific
infect
versu
noninfect
sampl
calcul
use
twotail
nonparametr
ttest
twotail
student
ttest
sampl
follow
normal
distribut
accord
test
welch
correct
appli
sampl
heterogen
varianc
correl
studi
twotail
nonparametr
spearman
analysi
use
p
valu
lower
deem
signific
identifi
lncrna
respond
ifn
treat
cell
unitsml
day
condit
serv
induc
express
wellknown
isg
oa
addit
treatment
induc
antivir
effect
hcvinfect
cell
treat
unitsml
show
decreas
level
viral
protein
viral
genom
compar
untreat
infect
cell
data
shown
final
rna
isol
cell
treat
unitsml
day
use
hybrid
agil
array
analysi
array
show
wellcharacter
isg
sever
member
gbp
oa
ifi
famili
upregul
high
statist
signific
b
ingenu
analysi
data
show
ifn
signal
pathway
highest
enrich
follow
antivir
respons
microarray
use
identifi
lncrna
regul
howev
array
evalu
express
level
transcript
hybrid
probe
spot
array
case
lncrna
array
use
address
express
region
describ
long
intergen
noncod
rna
lincrna
howev
estim
could
mani
lncrna
gene
code
gene
author
consid
number
lncrna
could
high
therefor
achiev
complet
identif
lncrna
respond
ifn
analyz
transcriptom
rnaseq
rna
isol
control
cell
cell
treat
ifn
describ
sequenc
ribodeplet
around
million
read
obtain
per
sampl
analysi
perform
use
bioinformat
workflow
includ
cufflink
describ
method
section
analysi
show
among
gene
upregul
respons
ifn
sever
isg
member
ifi
oa
famili
figur
tabl
supplementari
materi
ingenu
analysi
show
ifn
signal
top
canon
pathway
p
top
upstream
regul
p
cell
signal
infecti
inflammatori
diseas
among
main
function
express
code
gene
alter
ifn
tabl
supplementari
materi
rnaseq
analysi
also
show
express
level
mani
region
correspond
code
gene
also
significantli
modifi
respons
ifn
figur
put
noncod
gene
whose
express
significantli
alter
half
upregul
tabl
supplementari
materi
candid
visual
use
igv
figur
supplementari
materi
also
paid
special
attent
alter
sequenc
locat
close
wellknown
isg
genom
region
highli
express
deregul
respons
ifn
eight
candid
fulfil
least
one
two
criteria
chosen
valid
tabl
figur
supplementari
materi
valid
eight
candid
chosen
treat
cell
differ
dose
rna
isol
cell
h
posttreat
express
level
candid
evalu
quantit
rtpcr
qrtpcr
tabl
figur
candid
induc
ifntreat
howev
mani
candid
detect
low
cycl
pcr
amplif
closer
examin
sequenc
indic
contain
repetit
sequenc
sequenc
similar
mitochondri
ribosom
rna
could
led
erron
align
rnaseq
read
human
genom
believ
even
oligonucleotid
use
amplif
specif
partial
homolog
sequenc
could
allow
crossamplif
thu
increas
possibl
mislead
result
candid
studi
focus
two
lncrna
repetit
sequenc
whose
express
highli
upregul
respons
ifn
tabl
figur
interestingli
databas
analysi
show
express
posit
genom
locat
close
wellcharacter
isg
may
function
relev
lncrna
describ
regul
express
neighbor
gene
therefor
origin
name
lncrna
neighbor
later
renam
bispr
follow
hugo
regul
evalu
express
lncrna
neighbor
transcript
observ
strongli
upregul
earli
time
respons
ifn
figur
furthermor
respond
dose
low
unitsml
similar
level
found
sera
hcv
patient
induct
also
observ
late
time
postifntreat
evalu
robust
effect
ifn
lncrna
test
whether
also
respond
type
iii
ifn
cell
treat
h
also
show
increas
level
neighbor
figur
case
transcript
show
higher
upregul
later
time
treatment
virus
activ
ifn
respons
sever
mechan
therefor
evolv
block
ifn
product
activ
ifn
pathway
molecular
mechan
involv
ifn
blockad
character
mani
virus
thu
instanc
protein
influenza
viru
matrix
protein
vsv
key
factor
control
ifn
infect
cell
sought
check
whether
induc
physiolog
ifn
induc
influenza
viru
lack
therefor
evalu
express
lncrna
cell
infect
influenza
wildtyp
viru
mutant
also
includ
cell
infect
rna
virus
sfv
hcv
dna
virus
adenoviru
virus
develop
mechan
block
cellular
antivir
respons
except
hcv
lead
lytic
infect
differ
time
postinfect
evalu
last
point
collect
cytopath
effect
appar
occur
h
postinfect
case
influenza
sfv
h
postinfect
case
adenoviru
hcvinfect
cell
collect
h
postinfect
result
show
later
time
postinfect
influenza
viru
lack
increas
express
neighbor
code
transcript
figur
increas
observ
cell
infect
wildtyp
influenza
viru
wildtyp
lytic
virus
suggest
induct
may
mediat
ifn
lncrna
tissuespecif
determin
whether
respond
infect
cell
whether
effect
specif
influenza
virus
infect
alveolar
epitheli
cell
vsvgfp
wildtyp
viru
matrix
mutant
fail
control
ifn
chose
lung
cell
serv
primari
site
product
infect
vsv
mani
respiratori
virus
infect
wildtyp
viru
increas
express
data
shown
howev
cell
infect
vsv
mutant
h
show
increas
level
isg
figur
surprisingli
infect
hcv
also
increas
express
isg
includ
figur
data
shown
determin
whether
gene
also
upregul
infect
patient
use
liver
sampl
hcvneg
hcvposit
donor
quantif
rna
level
observ
signific
increas
hcvinfect
patient
compar
control
figur
number
patient
evalu
signific
correl
found
express
level
infect
particular
genotyp
hcv
presenc
hcvinduc
hepatocellular
carcinoma
hcc
liver
cirrhosi
particular
cirrhosi
stage
therefor
significantli
differ
level
transcript
hcvinfect
liver
without
hcc
compar
peritumor
tissu
hcvinfect
liver
hcc
although
sampl
belong
patient
still
aliv
signific
correl
observ
level
evalu
transcript
surviv
postdiagnosi
final
perform
correl
studi
analyz
whether
patient
express
level
correl
significantli
express
level
neighbor
code
gene
result
show
highli
signific
posit
correl
figur
experi
perform
far
suggest
gener
correl
could
exist
express
lncrna
neighbor
code
gene
similar
induct
pattern
respons
ifn
viral
infect
compar
level
figur
furthermor
level
codingnoncod
pair
correl
significantli
patient
sampl
figur
analyz
detail
perform
correl
studi
codingnoncod
pair
sampl
evalu
figur
result
show
correl
pair
highli
signific
figur
supplementari
materi
suggest
could
coregul
therefor
could
share
similar
function
howev
express
also
correl
significantli
express
isg
oa
data
shown
obtain
inform
relationship
codingnoncod
pair
search
sever
databas
gene
headtohead
orient
code
neighbor
figur
supplementari
materi
could
share
promot
base
follow
fact
distanc
two
gene
bp
cutoff
bidirect
promot
ii
singl
dnase
hypersensit
region
locat
gene
iii
polymeras
ii
pol
ii
chipseq
analysi
cell
show
singl
peak
cover
region
gene
interestingli
peak
observ
pol
ii
chipseq
increas
min
h
posttreat
final
promot
region
contain
conserv
isr
site
bind
sequenc
discrimin
whether
induc
directli
jakstat
signal
pathway
secondari
wave
ifn
respons
evalu
express
lncrna
code
neighbor
gene
cell
incub
jakstat
inhibitor
ruxolitinib
express
bona
fide
isg
also
evalu
posit
control
figur
result
show
level
significantli
reduc
presenc
ruxolitinib
indic
express
statdepend
level
also
reduc
cell
treat
sirna
target
inhibit
transcript
factor
act
downstream
ifn
data
shown
indic
respond
stat
also
transcript
factor
induc
ifn
result
agre
possibl
share
bidirect
promot
contrast
effect
jakstat
pathway
express
less
robust
treatment
ruxolitinib
decreas
express
latter
effect
observ
cell
effect
express
observ
milder
inhibit
inhibit
use
rna
interfer
data
shown
thu
although
induc
rapidli
ifntreat
observ
strong
regul
stat
pathway
condit
use
fact
report
major
regul
transcript
factor
activ
respons
pamp
also
downstream
effector
ifn
respons
evalu
code
capac
bioinformat
orf
finder
ncbi
use
determin
possibl
orf
lncrna
figur
supplementari
materi
analysi
show
put
orf
shorter
amino
acid
two
orf
could
translat
accord
poor
suscept
nonsens
mediat
decay
howev
orf
nonconsensu
kozak
sequenc
initi
codon
therefor
poor
code
capac
evalu
code
potenti
cpat
figur
cpat
use
model
built
orf
size
coverag
togeth
codon
ficket
score
hexam
hexam
score
usag
bia
accord
program
noncod
code
probabl
respect
much
lower
use
threshold
highest
sensit
specif
differenti
code
noncod
transcript
human
also
describ
noncod
lncipedia
lncrna
databas
show
lncrna
found
pride
archiv
databas
proteom
data
list
transcript
associ
ribosom
ribosom
profil
experi
also
describ
noncod
analysi
phylocsf
use
multipl
align
calcul
phylogenet
conserv
score
determin
whether
multispeci
nucleotid
sequenc
align
like
repres
proteincod
region
final
evalu
subcellular
local
cell
mocktreat
treat
unitsml
rna
isol
nuclear
cytoplasm
fraction
quantifi
qrtpcr
found
code
gapdh
mrna
accumul
preferenti
cytoplasm
nuclear
rna
preferenti
nuclear
figur
data
shown
similarli
compar
mrna
accumul
preferenti
nucleu
result
togeth
bioinformat
analys
strongli
suggest
noncod
rna
address
role
use
rna
interfer
cell
treat
ifn
transfect
sirna
target
rna
express
evalu
qrtpcr
result
show
express
decreas
compar
cell
transfect
control
sirna
figur
surprisingli
inhibit
also
led
decreas
level
mrna
express
express
gene
locat
genom
close
affect
figur
data
shown
determin
whether
gener
phenomenon
transfect
sirna
target
cell
infect
vsv
mutant
treat
ifn
similarli
observ
cell
sirna
target
lead
decreas
level
mrna
level
mrna
significantli
affect
figur
similar
result
observ
differ
sirna
target
rna
sequenc
analysi
human
cell
treat
control
allow
identif
lncrna
induc
respons
ifn
figur
analysi
rnaseq
data
show
sever
upregul
gene
wellknown
code
isg
oa
figur
tabl
supplementari
materi
ingenu
analysi
confirm
enrich
gene
involv
ifn
respons
among
regul
factor
use
rna
similar
ifntreat
control
cell
hybrid
express
array
comparison
dataset
obtain
analysi
array
rnaseq
show
code
gene
identifi
studi
includ
oa
member
ifi
famili
gener
overlap
microarray
rnaseq
analysi
high
furthermor
overlap
decreas
sequenc
depth
low
foldchang
low
abund
gene
analyz
sequenc
low
transcript
abund
character
high
varianc
imped
identif
rnaseq
analysi
believ
may
explain
poor
correl
found
array
rnaseq
dataset
fact
determin
qrtpcr
ifnrel
low
abund
transcript
detect
array
analysi
earli
respond
ifn
increas
margin
day
ifntreat
analysi
perform
therefor
believ
lncrna
induc
earli
postifntreat
may
identifi
analysi
interestingli
process
write
manuscript
paper
accept
describ
identif
ifninduc
lncrna
rnaseq
sampl
treat
ifn
short
time
believ
studi
complementari
work
togeth
dataset
contain
lncrna
regul
earli
later
time
postifntreat
similarli
lack
correl
microarray
rnaseq
dataset
also
indic
complement
identifi
two
lncrna
whose
express
highli
upregul
respons
differ
dose
tabl
figur
figur
result
show
induct
lncrna
seem
faster
observ
rule
possibl
fast
respons
may
also
observ
higher
dose
use
encod
analysi
polymeras
ii
bind
promot
lncrna
also
show
may
induc
treatment
figur
supplementari
materi
lncrna
name
neighbor
gene
play
key
role
antivir
ifn
respons
molecular
bioinformat
analys
strongli
suggest
inde
lncrna
accumul
preferenti
nucleu
ifntreat
untreat
cell
figur
poor
code
potenti
figur
figur
supplementari
materi
gener
upregul
mimic
code
counterpart
figur
fact
analysi
perform
express
data
obtain
studi
show
highli
signific
correl
signific
correl
also
exist
lncrna
ifninduc
gene
oa
figur
supplementari
materi
data
shown
may
reflect
fact
gene
induc
ifn
similar
kinet
case
lncrna
code
counterpart
correl
express
may
result
transcript
coregul
experiment
bioinformat
analys
indic
bona
fide
isg
strongli
induc
jakstat
pathway
respons
ifn
figur
figur
supplementari
materi
furthermor
express
neighbor
noncod
gene
induc
downstream
effector
ifn
respons
studi
allow
us
suggest
may
share
bidirect
promot
ifninduc
gene
pair
may
also
coregul
bidirect
promot
enrich
bind
bidirect
promot
often
coupl
gene
involv
process
allow
coordin
tempor
environment
respons
noncod
rna
gener
bidirect
promot
may
function
role
affect
bidirect
promot
neighbor
proteincod
gene
distal
gene
effect
could
lead
activ
repress
express
could
mediat
either
transcript
process
produc
ncrna
transcript
studi
show
posttranscript
inhibit
lead
reduc
level
mrna
figur
therefor
increas
transcript
stabil
code
neighbor
gene
result
demonstr
regul
seem
specif
downregul
affect
express
gene
locat
nearbi
describ
compact
genom
moreov
inhibit
affect
express
level
ifnrel
gene
figur
data
shown
anticip
inhibit
therefor
could
impact
antivir
effect
ifn
also
name
tetherin
inhibit
viral
bud
use
anchor
trap
virion
cell
membran
sever
envelop
virus
shown
suscept
action
evolv
develop
evas
strategi
interestingli
hiv
influenza
hcv
vsv
among
suscept
virus
could
use
test
antivir
role
fact
show
induc
infect
hcv
influenza
vsv
mutant
virus
activ
ifn
respons
figur
upregul
code
neighbor
also
observ
patient
infect
hcv
compar
control
figur
similarli
signific
upregul
also
detect
human
tlymphocyt
infect
hiv
compar
control
data
shown
nonsignific
increas
also
observ
sampl
lead
possibl
interfer
factor
could
therapeut
relev
unclear
cell
infect
virus
employ
sever
viral
protein
block
ifn
pathway
show
activ
ifn
respons
gene
case
hcv
previous
shown
patient
chronic
hcv
infect
express
isg
includ
high
level
fact
hcv
evolv
use
isg
viral
replic
case
ubiquitinlik
protein
attach
target
process
call
isgyl
protein
isgyl
may
result
increas
decreas
function
depend
target
preferenti
conjug
newli
synthes
protein
affect
strongli
viral
protein
cellular
protein
translat
ifninduc
cell
virus
influenza
hiv
vsv
suscept
action
case
hcv
prohcv
role
report
shown
neg
regul
rigi
thu
inhibit
signal
process
lead
ifn
induct
affect
hcv
replic
furthermor
express
liver
chronic
infect
patient
consid
neg
predict
biomark
abil
patient
respond
ifn
therapi
figur
studi
address
whether
marker
suscept
hcv
patient
respond
ifntreat
hcv
patient
studi
nonrespond
ifn
believ
similar
could
affect
express
gene
lncrnamedi
control
also
describ
lncrna
locat
close
isg
viperin
shown
regul
level
mani
ifninduc
gene
experi
requir
address
role
deciph
molecular
mechan
allow
control
exert
believ
studi
may
import
better
understand
ifn
respons
pro
antivir
function
hcv
virus
marina
barriocan
elena
carnero
design
perform
experi
analyz
interpret
data
marina
barriocan
contribut
write
manuscript
victor
segura
charg
bioinformat
analys
puri
fort
conceiv
project
requir
experi
provid
budget
interpret
data
wrote
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
review
editor
saba
valadkhan
declar
despit
collabor
public
last
year
author
puri
fort
marina
barriocan
elena
carnero
review
process
handl
object
